Revascularization options in stable coronary artery disease: it is not how to revascularize, it is whether and when to revascularize

被引:2
作者
Torosoff, Mikhail T. [1 ,2 ]
Sidhu, Mandeep S. [1 ,2 ,3 ]
Desai, Karan P. [4 ]
Fein, Steven A. [1 ,2 ]
Boden, William E. [1 ,2 ,3 ]
机构
[1] Albany Med Ctr, Dept Med, Div Cardiol, Albany, NY 12208 USA
[2] Albany Med Coll, Albany, NY 12208 USA
[3] Samuel S Stratton VA Med Ctr, Albany, NY USA
[4] Johns Hopkins Sch Med, Dept Med, Baltimore, MD USA
关键词
coronary anatomy; coronary artery disease; ischemia; myocardial ischemia; optimal medical therapy; revascularization; stable ischemic heart disease; OPTIMAL MEDICAL THERAPY; CONTROLLED CLINICAL-TRIAL; FRACTIONAL FLOW RESERVE; OUTCOMES UTILIZING REVASCULARIZATION; 10-YEAR FOLLOW-UP; QUALITY-OF-LIFE; MASS-II; MYOCARDIAL-ISCHEMIA; COST-EFFECTIVENESS; STENT THROMBOSIS;
D O I
10.2217/cer.15.37
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Patients with acute coronary syndromes and severe multivessel or left main coronary artery disease have better outcomes when prompt revascularization is performed in addition to optimal medical therapy (OMT). However, in patients with stable ischemic heart disease, randomized strategy trials have revealed equipoise between initial strategies of OMT alone and OMT plus revascularization. Conducted in diverse stable ischemic heart disease patient populations and throughout the spectrum of atherosclerotic and ischemic burden, the RITA-2, MASS II, COURAGE, BARI 2D and FAME 2 trials demonstrate that OMT alone and OMT plus revascularization yield similar outcomes with respect to mortality and myocardial infarction. What remains unclear is whether there may be one or more subsets of patients with stable ischemic heart disease in whom revascularization may be associated with a reduction in mortality or myocardial infarction, which is to be addressed in the ongoing ISCHEMIA trial.
引用
收藏
页码:505 / 514
页数:10
相关论文
共 51 条
[31]   Predicting Outcome in the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) Coronary Anatomy Versus Ischemia [J].
Mancini, G. B. John ;
Hartigan, Pamela M. ;
Shaw, Leslee J. ;
Berman, Daniel S. ;
Hayes, Sean W. ;
Bates, Eric R. ;
Maron, David J. ;
Teo, Koon ;
Sedlis, Steven P. ;
Chaitman, Bernard R. ;
Weintraub, William S. ;
Spertus, John A. ;
Kostuk, William J. ;
Dada, Marcin ;
Booth, David C. ;
Boden, William E. .
JACC-CARDIOVASCULAR INTERVENTIONS, 2014, 7 (02) :195-201
[32]   In Mildly Symptomatic Patients, Should an Invasive Strategy with Catheterization and Revascularization Be Routinely Undertaken? In Mildly Symptomatic Patients, an Invasive Strategy with Catheterization and Revascularization Should Not Be Routinely Undertaken [J].
Maron, David J. ;
Ting, Henry H. .
CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2013, 6 (01) :114-121
[33]   Impact of an Initial Strategy of Medical Therapy Without Percutaneous Coronary Intervention in High-Risk Patients From the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) Trial [J].
Maron, David J. ;
Spertus, John A. ;
Mancini, G. B. John ;
Hartigan, Pamela M. ;
Sedlis, Steven P. ;
Bates, Eric R. ;
Kostuk, William J. ;
Dada, Marcin ;
Berman, Daniel S. ;
Shaw, Leslee J. ;
Chaitman, Bernard R. ;
Teo, Koon K. ;
O'Rourke, Robert A. ;
Weintraub, William S. ;
Boden, William E. .
AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (08) :1055-1062
[34]   2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines [J].
O'Gara, Patrick T. ;
Kushner, Frederick G. ;
Ascheim, Deborah D. ;
Casey, Donald E., Jr. ;
Chung, Mina K. ;
de Lemos, James A. ;
Ettinger, Steven M. ;
Fang, James C. ;
Fesmire, Francis M. ;
Franklin, Barry A. ;
Granger, Christopher B. ;
Krumholz, Harlan M. ;
Linderbaum, Jane A. ;
Morrow, David A. ;
Newby, L. Kristin ;
Ornato, Joseph P. ;
Ou, Narith ;
Radford, Martha J. ;
Tamis-Holland, Jacqueline E. ;
Tommaso, Carl L. ;
Tracy, Cynthia M. ;
Woo, Y. Joseph ;
Zhao, David X. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (04) :E78-E140
[35]   Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis [J].
Palmerini, Tullio ;
Biondi-Zoccai, Giuseppe ;
Della Riva, Diego ;
Stettler, Christoph ;
Sangiorgi, Diego ;
D'Ascenzo, Fabrizio ;
Kimura, Takeshi ;
Briguori, Carlo ;
Sabate, Manel ;
Kim, Hyo-Soo ;
De Waha, Antoinette ;
Kedhi, Elvin ;
Smits, Pieter C. ;
Kaiser, Christoph ;
Sardella, Gennaro ;
Marullo, Antonino ;
Kirtane, Ajay J. ;
Leon, Martin B. ;
Stone, Gregg W. .
LANCET, 2012, 379 (9824) :1393-1402
[36]   Inducible Myocardial Ischemia and Outcomes in Patients With Coronary Artery Disease and Left Ventricular Dysfunction [J].
Panza, Julio A. ;
Holly, Thomas A. ;
Asch, Federico M. ;
She, Lilin ;
Pellikka, Patricia A. ;
Velazquez, Eric J. ;
Lee, Kerry L. ;
Borges-Neto, Salvador ;
Farsky, Pedro S. ;
Jones, Robert H. ;
Berman, Daniel S. ;
Bonow, Robert O. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (18) :1860-1870
[37]   A RANDOMIZED TRIAL OF CORONARY-ARTERY BYPASS-SURGERY - SURVIVAL OF PATIENTS WITH A LOW EJECTION FRACTION [J].
PASSAMANI, E ;
DAVIS, KB ;
GILLESPIE, MJ ;
KILLIP, T .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (26) :1665-1671
[38]   Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses [J].
Pijls, NHJ ;
DeBruyne, B ;
Peels, K ;
VanderVoort, PH ;
Bonnier, HJRM ;
Bartunek, J ;
Koolen, JJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (26) :1703-1708
[39]   Quality of life after coronary angioplasty or continued medical treatment for angina: Three-year follow-up in the RITA-2 trial [J].
Pocock, SJ ;
Henderson, RA ;
Clayton, T ;
Lyman, GH ;
Chamberlain, DA .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (04) :907-914
[40]   Should Percutaneous Revascularization for Stable Coronary Artery Disease Be Performed Sooner or Later? [J].
Prasad, Abhiram ;
Gersh, Bernard J. .
JACC-CARDIOVASCULAR INTERVENTIONS, 2008, 1 (05) :480-482